Finance

Lists
001065:KRX
JW Pharmaceutical(1P) Pref Shs
21 300,00 KRW
0,00%
(0,00) 1D
16-окт., 15:30:30 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 001065...
Open
21 300 KRW
High
21 300 KRW
Low
21 100 KRW
Mkt. cap
607,55 млд
Avg. vol.
122,00
Volume
34,00
Dividend
3,05%
Quarterly dividend
162 KRW
Ex-dividend date
2023-ж., 27-дек.
P/E ratio
5,08
52-wk high
30 300 KRW
52-wk low
19 710 KRW
EPS
4 193 KRW
Shares outstanding
341,95 миң
No. of employees
1 миң
Open
21 300 KRW
High
21 300 KRW
Low
21 100 KRW
Mkt. cap
607,55 млд
Avg. vol.
122,00
Volume
34,00
Dividend
3,05%
Quarterly dividend
162 KRW
Ex-dividend date
2023-ж., 27-дек.
P/E ratio
5,08
52-wk high
30 300 KRW
52-wk low
19 710 KRW
EPS
4 193 KRW
Shares outstanding
341,95 миң
No. of employees
1 миң
News stories
From web sources and news partners
About JW Pharmaceutical(1P) Pref Shs
CEOLee, Kyung Ha
Employees1,05 миң
Founded1945
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
200,02 млд
198,94 млд
199,88 млд
222,02 млд
Cost of goods sold
105,39 млд
109,09 млд
101,43 млд
116,73 млд
Cost of revenue
105,39 млд
109,09 млд
101,43 млд
116,73 млд
Research and development expenses
7,33 млд
15,27 млд
9,38 млд
11,86 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
55,58 млд
60,42 млд
55,91 млд
59,90 млд
Operating expense
62,60 млд
80,98 млд
64,88 млд
71,95 млд
Total operating expenses
167,99 млд
190,07 млд
166,31 млд
188,68 млд
Operating income
32,03 млд
8,87 млд
33,58 млд
33,34 млд
Other non operating income
-4,64 млд
8,03 млд
1,21 млд
835,27 млн
EBT including unusual items
27,85 млд
17,49 млд
35,20 млд
34,76 млд
EBT excluding unusual items
27,85 млд
15,96 млд
35,20 млд
34,76 млд
Income tax expense
-2,74 млд
2,18 млд
7,72 млд
6,86 млд
Effective tax rate
-9,83%
12,44%
21,93%
19,75%
Other operating expenses
-
-
-
-
Net income
30,59 млд
15,32 млд
27,48 млд
27,89 млд
Net profit margin
15,29%
7,70%
13,75%
12,56%
Earnings per share
1,27 миң
-
-
-
Interest and investment income
-
3,34 млд
-
-
Interest expense
-
-4,42 млд
-
-
Net interest expenses
-
-1,09 млд
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
36,72 млд
13,65 млд
38,56 млд
38,37 млд
Gain or loss from assets sale
5,12 млн
3,00 миң
-10,00 млн
3,00 миң
AI content may include mistakes. Learn more
Google колдонмолору